Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2016 (2016), Article ID 8297407, 8 pages
http://dx.doi.org/10.1155/2016/8297407
Research Article

Pregnancy and Birth Outcomes among Women with Idiopathic Thrombocytopenic Purpura

1Pregistry, Los Angeles, CA 90045, USA
2Epidemiology, OptumInsight, Waltham, MA 02451, USA
3Children’s Hospital Boston, Boston, MA 02115, USA
4Medical Genetics Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
5Palo Alto Medical Foundation, Mountain View, CA 94040, USA
6Department of Pediatrics, Division of Genetics, University of California, San Francisco, San Francisco, CA 94115, USA
7College of Public Health, University of South Florida, Tampa, FL 33612, USA
8Department of Medicine, Division of Pharmacoeconomics and Pharmacoepidemiology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA 02120, USA

Received 29 October 2015; Accepted 3 March 2016

Academic Editor: Albert Fortuny

Copyright © 2016 Diego F. Wyszynski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. N. George, S. H. Woolf, G. E. Raskob et al., “Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology,” Blood, vol. 88, no. 1, pp. 3–40, 1996. View at Google Scholar · View at Scopus
  2. J. N. George, G. E. Raskob, S. R. Shah et al., “Drug-induced thrombocytopenia: a systematic review of published case reports,” Annals of Internal Medicine, vol. 129, no. 11, pp. 886–890, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Klaassen, S. D. Mathias, G. Buchanan et al., “Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP),” Pediatric Blood and Cancer, vol. 58, no. 3, pp. 395–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. G. Kelton, “Idiopathic thrombocytopenic purpura complicating pregnancy,” Blood Reviews, vol. 16, no. 1, pp. 43–46, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. K. Gill and J. G. Kelton, “Management of idiopathic thrombocytopenic purpura in pregnancy,” Seminars in Hematology, vol. 37, no. 3, pp. 275–289, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Fujita, R. Sakai, S. Matsuura et al., “A retrospective analysis of obstetric patients with idiopathic thrombocytopenic purpura: a single center study,” International Journal of Hematology, vol. 92, no. 3, pp. 463–467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Suri, N. Aggarwal, S. Saxena, P. Malhotra, and S. Varma, “Maternal and perinatal outcome in idiopathic thrombocytopenic purpura (ITP) with pregnancy,” Acta Obstetricia et Gynecologica Scandinavica, vol. 85, no. 12, pp. 1430–1435, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. F. E. Al-Jama, J. Rahman, S. A. Al-Suleiman, and M. S. Rahman, “Outcome of pregnancy in women with idiopathic thrombocytopenic purpura,” The Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 38, no. 4, pp. 410–413, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Belkin, A. Levy, and E. Sheiner, “Perinatal outcomes and complications of pregnancy in women with immune thrombocytopenic purpura,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 22, no. 11, pp. 1081–1085, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. E. Webert, R. Mittal, C. Sigouin, N. M. Heddle, and J. G. Kelton, “A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura,” Blood, vol. 102, no. 13, pp. 4306–4311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-W. Won, W. Moon, Y.-S. Yun et al., “Clinical aspects of pregnancy and delivery in patients with chronic idiopathic thrombocytopenic purpura (ITP),” Korean Journal of Internal Medicine, vol. 20, no. 2, pp. 129–134, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Chao, C. M. Zeng, and J. Liu, “Thrombocytopenia in pregnancy and neonatal outcomes,” Zhongguo Dang Dai Er Ke Za Zhi, vol. 13, pp. 790–793, 2011. View at Google Scholar
  13. D.-P. Wang, M.-Y. Liang, and S.-M. Wang, “Clinical analysis of pregnancy complicated with severe thrombocytopenia,” Zhonghua Fu Chan Ke Za Zhi, vol. 45, no. 6, pp. 401–405, 2010. View at Google Scholar · View at Scopus
  14. O. Debouverie, P. Roblot, F. Roy-Péaud, C. Boinot, F. Pierre, and O. Pourrat, “Chronic idiopathic thrombocytopenia outcome during pregnancy (62 cases),” Revue de Medecine Interne, vol. 33, no. 8, pp. 426–432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Namavar Jahromi, Z. Shiravani, and L. Salarian, “Perinatal outcome of pregnancies complicated by immune thrombocytopenia,” Iranian Red Crescent Medical Journal, vol. 14, no. 7, pp. 430–435, 2012. View at Google Scholar · View at Scopus
  16. J. A. Cole, J. G. Modell, B. R. Haight, I. S. Cosmatos, J. M. Stoler, and A. M. Walker, “Bupropion in pregnancy and the prevalence of congenital malformations,” Pharmacoepidemiology and Drug Safety, vol. 16, no. 5, pp. 474–484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Cole, S. A. Ephross, I. S. Cosmatos, and A. M. Walker, “Paroxetine in the first trimester and the prevalence of congenital malformations,” Pharmacoepidemiology and Drug Safety, vol. 16, no. 10, pp. 1075–1085, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. C. Matzdorff, G. Arnold, A. Salama, H. Ostermann, S. Eberle, and S. Hummler, “Advances in ITP—therapy and quality of life—a patient survey,” PLoS ONE, vol. 6, no. 11, Article ID e27350, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Koyama, T. Tomimatsu, T. Kanagawa, K. Kumasawa, T. Tsutsui, and T. Kimura, “Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura,” American Journal of Hematology, vol. 87, no. 1, pp. 15–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Tampakoudis, H. Bili, E. Lazaridis, E. Anastasiadou, A. Andreou, and S. Mantalenakis, “Prenatal diagnosis of intracranial hemorrhage secondary to maternal idiopathic thrombocytopenic purpura: a case report,” American Journal of Perinatology, vol. 12, no. 4, pp. 268–270, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. M. W. Kim and H. M. Choi, “Fetal hydrocephalus in a pregnancy complicated by idiopathic thrombocytopenic purpura,” Journal of Ultrasound in Medicine, vol. 25, no. 6, pp. 777–780, 2006. View at Google Scholar · View at Scopus
  22. P. Moons, T. Sluysmans, D. De Wolf et al., “Congenital heart disease in 111 225 births in Belgium: birth prevalence, treatment and survival in the 21st century,” Acta Paediatrica, vol. 98, no. 3, pp. 472–477, 2009. View at Publisher · View at Google Scholar · View at Scopus